fda semaglutide warning september 2025 Sends Letters to More Than 50 GLP-1 Compounders and Manufacturers Novo's Wegovy adds another indication

When side effects indicate a dosing problem Normal side effects are uncomfortable but manageable

Across 32,598 women in the development programmes, 164 unplanned pregnancies were recorded

Ozempic was originally developed to lower blood sugar in patients with type 2 diabetes

Gastrointestinal adverse effects are common with semaglutide, including nausea, vomiting, diarrhoea, and constipation

However, compounded GLP-1s are not FDA-approved and, as a result, come with a level of risk

Since the transaction happens within an eligible system, you are less likely to receive follow-up requests from your plan administrator